J Microencapsul. 2026 Jul 3:1-32. doi: 10.1080/02652048.2026.2695092. Online ahead of print.
ABSTRACT
BACKGROUND: Acne vulgaris is a prevalent inflammatory dermatosis in which Cutibacterium acnes, Staphylococcus epidermidis, and, to a lesser extent, Staphylococcus aureus play central pathogenic roles. Conventional therapies (retinoids, antibiotics, corticosteroids) are limited by resistance, irritation, and suboptimal long-term efficacy.
OBJECTIVE AND METHODOLOGY: Essential oils (EOs) exhibit diverse biological activities, yet their clinical translation is constrained by volatility, physicochemical instability and poor follicular penetration. This review systematically examines EO-loaded nano-delivery systems including nanogels, liposomes, solid lipid nanoparticles and nanostructured lipid carriers as strategies to enhance overall release. Special emphasis is placed on multiscale in silico tools and statistical optimisation approaches for rational formulation engineering. Representative case studies and current insights into nano-toxicity and safety assessment are critically appraised to guide future clinical translation.
CONCLUSION: Advancing priorities including personalised dermatology frameworks, microbiome-responsive, folliculotropic EO nanocarriers and integrated computational approaches will accelerate the development of scalable, and patient-centered EO based nanoformulations for acne.
PMID:42396630 | DOI:10.1080/02652048.2026.2695092
